Flavin Richard J, Smyth Paul C, Laios Alexandros, O'Toole Sharon A, Barrett Ciara, Finn Stephen P, Russell Susan, Ring Martina, Denning Karen M, Li Jinghuan, Aherne Sinead T, Sammarae Dania A, Aziz Natasha A, Alhadi Araibi, Sheppard Brian L, Lao Kai, Sheils Orla M, O'Leary John J
Department of Histopathology, Trinity College Dublin, Dublin, Ireland.
Mod Pathol. 2009 Feb;22(2):197-205. doi: 10.1038/modpathol.2008.135. Epub 2008 Aug 1.
MicroRNAs are a group of small non-coding RNAs approximately 22 nucleotides in length. Recent work has shown differential expression of mature microRNAs in human cancers. We characterized the alteration in expression of a select group of microRNAs in primary peritoneal carcinoma relative to matched cases of ovarian serous carcinoma. MicroRNA expression was analysed using semi-quantitative stem-loop RT-PCR on a set of 34 formalin-fixed paraffin-embedded samples. Protein expression of p53 and bcl-2 was quantified in the corresponding tissue microarray. We provide definitive evidence that there is downregulation of a select group of microRNAs in tumours meeting Gynaecological Oncology Group criteria for primary peritoneal carcinoma relative to ovarian serous carcinoma. Specifically, we show decreased p53 expression and downregulation of miR-195 and miR-497 from the microRNA cluster site at chromosome 17p13.1 in primary peritoneal carcinoma relative to ovarian serous carcinoma. miR-195 and miR-497 may have potential roles as tumour-suppressor genes in primary peritoneal tumourigenesis.
微小RNA是一组长度约为22个核苷酸的小型非编码RNA。最近的研究表明,成熟微小RNA在人类癌症中存在差异表达。我们对原发性腹膜癌中一组特定微小RNA相对于配对的卵巢浆液性癌病例的表达变化进行了表征。使用半定量茎环RT-PCR对一组34个福尔马林固定石蜡包埋样本进行微小RNA表达分析。在相应的组织微阵列中对p53和bcl-2的蛋白表达进行定量。我们提供了确凿的证据,即相对于卵巢浆液性癌,符合妇科肿瘤学组原发性腹膜癌标准的肿瘤中一组特定微小RNA存在下调。具体而言,我们发现相对于卵巢浆液性癌,原发性腹膜癌中p53表达降低,并且位于17号染色体p13.1的微小RNA簇位点的miR-195和miR-497下调。miR-195和miR-497可能在原发性腹膜肿瘤发生中作为肿瘤抑制基因发挥潜在作用。